![Favorite pages[Japanese page]](/files/000137013.png){kind=small}
](/files/000137010.png){kind=small}
Here begins the text.
Pmda Pharmaceuticals and Medical Devices Agency
What's newBack number
August 22, 2019Revisions of PRECAUTIONS:Apomorphine hydrochloride hydrate etc., posted
- August 16, 2019Notifications and Administrative Notices: PFSB/MDRMPED Notification No. 1121-33, No. 1125-6, No. 0219-1, and 2 PFSB/MDRMPED Administrative Notices
- August 14, 2019List of Approved Products (New Drugs): FY2019 (April - June 2019)
- August 14, 2019English Translation of Review Report: Vyndaqel (Partial Change Approval)
- August 14, 2019English translation of review report: RFA System and Cool-tip RFA System E Series
- August 16, 2019Notifications and Administrative Notices: PFSB/MDRMPED Notification No. 1121-33, No. 1125-6, No. 0219-1, and 2 PFSB/MDRMPED Administrative Notices
- August 14, 2019List of Approved Products (New Drugs): FY2019 (April - June 2019)
- August 14, 2019English Translation of Review Report: Vyndaqel (Partial Change Approval)
- August 14, 2019English translation of review report: RFA System and Cool-tip RFA System E Series
- Currently, there is no applicable information.
- Currently, there is no applicable information.
- Currently, there is no applicable information.
